HEIDELBERG, Germany,
April 18, 2024 /PRNewswire/ -- The
European Wellness Biomedical Group (EWBG), in collaboration with
the European Wellness Academy (EWA), the Baden Research Lab, and
Heidelberg University, has announced substantial advances in Down
Syndrome research, revealing new neuroanatomical insights that open
the way for novel care methods.
This groundbreaking study, conducted by pioneers in
bioregenerative medicine and education, uses modern MRI methods to
demonstrate a link between cognitive ability and brain volume
changes in people with Down Syndrome. These findings suggest that
early intervention techniques enhance the quality of life for
individuals afflicted.
EWBG, known for its groundbreaking work in stem cell therapy,
has been at the forefront of this study, working closely with
Heidelberg University. This collaboration demonstrates a shared
commitment to transforming the care and treatment of Down Syndrome
and associated diseases via cutting-edge scientific
breakthroughs.
Prof. Dr Mike Chan, a crucial
contributor in the study, emphasised the importance of
bioregenerative medicine in this research. "Our findings represent
a major step forward in understanding Down Syndrome," stated Prof.
Dr Mike Chan. "Through applying stem
cell therapy and other advanced treatments, we envision a future
where tailored-care can significantly improve outcomes for these
individuals."
The European Wellness Academy is critical in offering advanced
training for healthcare professionals participating in this
research, ensuring that the most recent advancements in
bioregenerative medicine are incorporated into clinical practices.
Meanwhile, Baden concentrates on creating a conducive research
environment while Heidelberg University grows as a global leader in
stem cell research and immunology, advancing the study's goals.
This joint project is a watershed moment in Down Syndrome
research, setting a new standard for tackling and treating
complicated neurological illnesses. By leveraging the potential of
bioregenerative medicine, the partners engaged are making
tremendous progress toward a future in which tailored and effective
care for Down Syndrome is not only a possibility, but a
reality.
CONTACT: EW Group Media
Team, media@european-wellness.com
Logo -
https://mma.prnewswire.com/media/2362609/EW_COLOR_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/european-wellness-leads-pioneering-down-syndrome-research-at-heidelberg-university-302120741.html